We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.27%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$49B
AUM Growth
+$3.11B
(+6.8%)
Cap. Flow
+$228M
Cap. Flow
% of AUM
0.47%
Top 10 Holdings %
Top 10 Hldgs %
21.37%
Holding
1,104
New
303
Increased
294
Reduced
324
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$282M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$205M |
| 3 |
ConocoPhillips
COP
|
+$203M |
| 4 |
Fortive
FTV
|
+$200M |
| 5 |
Merck
MRK
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$665M |
| 2 |
ExxonMobil
XOM
|
+$332M |
| 3 |
Burlington
BURL
|
+$242M |
| 4 |
National Vision
EYE
|
+$186M |
| 5 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.67% |
| 2 | Healthcare | 17.99% |
| 3 | Financials | 14.03% |
| 4 | Consumer Discretionary | 11.97% |
| 5 | Communication Services | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SJI
476
DELISTED
South Jersey Industries, Inc.
SJI
| $19.2M | 0.04% |
+850,000
| New | +$20.1M |
|
477
Alaska Air
ALK
$5.58B
| $19.1M | 0.04% |
275,917
-17,623
| -6% | -$1.06M |
|
|
RCHG
478
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
| $19.1M | 0.04% |
1,950,000
| – | – |
|
|
DLCA
479
DELISTED
Deep Lake Capital Acquisition Corp. Class A Ordinary Shares
DLCA
| $19.1M | 0.04% |
+1,944,469
| New | +$19M |
|
480
MDU Resources
MDU
$4.32B
| $19M | 0.04% |
+1,577,931
| New | +$17.2M |
|
481
Cencora
COR
$61.2B
| $18.9M | 0.04% |
160,500
-3,100
| -2% | -$335K |
|
482
Healthpeak Properties
DOC
$14.8B
| $18.9M | 0.04% |
595,743
+12,100
| +2% | +$367K |
|
483
Albemarle
ALB
$15.5B
| $18.8M | 0.04% |
128,579
+10,600
| +9% | +$1.7M |
|
|
JWSM.U
484
DELISTED
Jaws Mustang Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-fourth of one redeemable warrant
JWSM.U
| $18.8M | 0.04% |
+1,850,000
| New | +$19.3M |
|
485
Warner Bros
WBD
$67.1B
| $18.7M | 0.04% |
429,811
+251,365
| +141% | +$12.6M |
|
486
Jacobs Solutions
J
$17B
| $18.6M | 0.04% |
174,245
+3,750
| +2% | +$358K |
|
487
Northern Trust
NTRS
$33.9B
| $18.5M | 0.04% |
175,600
-16,400
| -9% | -$1.61M |
|
488
Nasdaq
NDAQ
$52.9B
| $18.3M | 0.04% |
372,840
-7,200
| -2% | -$342K |
|
489
BioCryst Pharmaceuticals
BCRX
$2.4B
| $18.3M | 0.04% |
1,800,000
+200,000
| +13% | +$2.06M |
|
490
Western Digital
WDC
$150B
| $18.3M | 0.04% |
362,683
-15,082
| -4% | -$705K |
|
491
W.W. Grainger
GWW
$60.2B
| $18.3M | 0.04% |
45,571
+4,300
| +10% | +$1.66M |
|
492
Akamai
AKAM
$15.9B
| $18.2M | 0.04% |
179,000
+48,700
| +37% | +$5.03M |
|
493
XPO
XPO
$23.7B
| $18.2M | 0.04% |
+426,362
| New | +$17.7M |
|
494
Verisk Analytics
VRSK
$25B
| $18.2M | 0.04% |
102,800
-74,900
| -42% | -$13.7M |
|
495
Stellantis
STLA
$20.8B
| $18.2M | 0.04% |
+1,020,724
| New | +$17.2M |
|
496
Gartner
IT
$11.7B
| $18.1M | 0.04% |
99,300
+1,100
| +1% | +$191K |
|
|
GRNA
497
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $17.9M | 0.04% |
+1,850,000
| New | +$18.2M |
|
498
SES AI
SES
$208M
| $17.8M | 0.04% |
+1,800,000
| New | +$18.1M |
|
499
NVR
NVR
$17B
| $17.7M | 0.04% |
3,756
-36
| -0.9% | -$162K |
|
|
VAR
500
DELISTED
Varian Medical Systems, Inc.
VAR
| $17.6M | 0.04% |
99,959
+600
| +0.6% | +$106K |
|
Similar funds
Adage Capital Partners's Q1 2021 Portfolio in Review
As of Q1 2021, Adage Capital Partners held 1,104 positions worth $49B, up 6.8% from $45.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Adage Capital Partners's Q1 2021 filing shows 303 new, 294 increased, 324 reduced and 153 closed positions. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M. The largest sale was Royalty Pharma, an estimated $665M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
- Adage Capital Partners's largest Q1 2021 buy was GW Pharmaceuticals Plc American Depositary Shares: 1,500,000 shares worth $325M.
- Adage Capital Partners added most to Alexion Pharmaceuticals in Q1 2021, an estimated $205M increase.
- Adage Capital Partners's biggest Q1 2021 reduction was Royalty Pharma, cutting an estimated $665M.
- Adage Capital Partners fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $175M.
- Adage Capital Partners's ten largest holdings make up 21% of its $49B portfolio in Q1 2021.
- Adage Capital Partners opened 303 new positions and closed 153 in Q1 2021.
- Adage Capital Partners's portfolio value rose 6.8% quarter-over-quarter to $49B.
Based on Adage Capital Partners's 13F filing for Q1 2021, filed 17 May 2021.